drugset / Trial / NCT06395844
Safety and Efficacy of Intraperitoneal Injection of METR-NK Cells as Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer
Phase 1/2
Recruiting
28 enrolled
Anhui Provincial Cancer Hospital
Anhui Kecheng intelligent health technology Co., LTD · collab
NaSingle-groupOpen-labelTreatment
Summary
The goal of this type of clinical trial study is to evaluate the safety and efficacy of metabolic remodeling nature killer cells as neoadjuvant therapy in newly diagnosed patients with advanced ovarian cancer
Timeline
- Start
- 2024-05-01
- Primary completion
- 2025-05-01
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | METR-NK cell | Unknown | 7.5e+07 cells/kg | Other |